Gynecologic Oncology Program

Appointments Group of seven young to middle aged women of different races
  • About
  • Approach
  • Services
  • Appointments
  • Research
  • Locations
  • Doctors
  • Providers
    • USNWR High Performing Gynecological Cancer Surgery | 2026-27

    The U-M Health Rogel Cancer Center's Gynecologic Oncology Program is a team of fellowship-trained gynecologic oncologists providing comprehensive, personalized cancer care. We follow National Comprehensive Cancer Network (NCCN) guidelines to develop treatment plans tailored to each patient’s diagnosis, stage, and goals. As an NCCN founding member institution, we offer access to the latest evidence-based treatments and the most clinical trials available for each disease.

    Our Approach
    • New treatments that offer hope: We meet you where you are with fresh perspectives and customized treatment plans, including clinical trials.
    • Comprehensive gynecologic cancer care: Our board-certified gynecologic cancer specialists meet regularly to share their expertise with one another. We bring our experts together to focus on one goal: your care and comfort. We don’t take a one-size-fits-all approach to treatment — your care is always thorough and personalized to you.
    • Comfort and convenience: Your team makes sure you have what you need to feel comfortable throughout diagnosis, treatment and follow-up care. We offer educational tools and virtual appointments.  
    • Support Services and Resources for Gastrointestinal Gynecologic Cancers:  You never face cancer alone at Rogel Cancer Center. We have Patient and Family Support Services which offer a variety of information, assistance and other types of supportive care. Our cancer center partners with local and national organizations to help you get the support you need.
    • Leading-edge research: Our focus on academic research means you have access to the latest treatments. We offer clinical trials for eligible patients to receive promising new therapies not widely available. And we continuously track patient outcomes to make sure we’re delivering the highest-quality care.
    GynOnc Chemotherapy Visit Video

    Services

    Our gynecologic oncology surgical services include a full range of gynecologic procedures, including:

    Outpatient services for evaluation and treatment of pre-invasive vulvar, vaginal and cervical diseases include colposcopy (a follow-up exam for an abnormal Pap smear), laser and loop electrosurgical excision (to test abnormal cervix tissue) procedures. Should you have abnormal Pap smears, dysplasia, vaginal intraepithelial neoplasia, cervical intraepithelial neoplasia or squamous intraepithelial lesion, carcinoma in situ, condyloma (genital warts) or human papilloma virus (HPV), you could be seen in our Colposcopy Clinic.

    We also offer the latest chemotherapy research processes that use both investigational and approved medications for a wide range of gynecologic malignancies.

    Learn more in our Online Patient Library.

    Conditions

     Cervical Cancer

    When treating cervical cancer, our plan of action includes a number of treatment options, as appropriate for the stage and grade of your cancer. Our treatments include:

    • Surgery
    • Chemotherapy
    • Radiation therapy
    • Targeted therapy
    • Immunotherapy

    Advanced Cervical Cancer

    We are a referral center for advanced cervical cancer, offering specialized interstitial brachytherapy — a highly focused form of radiation delivered directly to the tumor. This advanced treatment is available at very few hospitals in Michigan. Your physician will discuss whether this option is appropriate for you.

    Clinical Trials

    We prioritize clinical trials and have access to the most trials open for cervical cancer. Ask your physician if a clinical trial may be right for you.  Learn more about clinical trials by visiting our Clinical Trials for Cancer Patients webpage.

         Gestational trophoplastic disease (GTD)

    Gestational trophoplastic disease (GTD) is a group of tumors that develop from the abnormal growth of cells inside the uterus (womb) that would normally develop into the placenta (the organ that passes nutrients from the mother to the fetus) during pregnancy.

    All types of GTD can be treated and treatment often results in a complete cure. The treatment for GTD depends on the specific type of tumor, stage, and other factors. 

         Ovarian & Tubular Cancer

    Ovarian and tubal cancers are treated as a single disease. Our physicians use a combination of the following approaches based on the stage and type of your cancer:

    • Surgery, including cytoreductive (debulking) surgery
    • Minimally invasive surgery (laparoscopy/robotics), when appropriate
    • Heated Intraperitoneal Chemotherapy (HIPEC) — chemotherapy delivered directly into the abdomen during surgery
    • Chemotherapy
    • Targeted therapy
    • Immunotherapy
    • Endocrine (hormonal) therapy
    • Fertility preservation options for carefully selected patients

    Clinical Trials

    We prioritize clinical trials and have access to the most trials open for cervical cancer. Ask your physician if a clinical trial may be right for you.  Learn more about clinical trials by visiting our Clinical Trials for Cancer Patients webpage.

         Uterine & Endometrial Cancer

    Our approach to endometrial and uterine cancer is guided by the stage and grade of disease determined by our expert pathologists. Treatments include:

    • Minimally invasive surgery (laparoscopy/robotics) — prioritized when appropriate
    • Chemotherapy
    • Targeted therapy
    • Antibody-drug conjugates
    • Hormonal therapy
    • Fertility preservation options for carefully selected patients

    Clinical Trials

    We prioritize clinical trials and have access to the most trials open for cervical cancer. Ask your physician if a clinical trial may be right for you.  Learn more about clinical trials by visiting our Clinical Trials for Cancer Patients webpage.

    All treatment decisions follow NCCN guidelines.

         Vulvar Cancer

    We utilize a combination of surgery, chemotherapy, and radiation therapy as appropriate for the stage and grade of your vulvar cancer. Our treatments include:

    • Surgery
    • Chemotherapy
    • Radiation therapy
    • Targeted therapy
    • Immunotherapy

    Clinical Trials

    We prioritize clinical trials and have access to the most trials open for cervical cancer. Ask your physician if a clinical trial may be right for you.  Learn more about clinical trials by visiting our Clinical Trials for Cancer Patients webpage.

    Appointment Information

    If you've been diagnosed with a gynecologic cancer, or suspect you may have one, please call 734-647-8902.

    If you're referring a patient, please contact M-Line 800-962-3555.

    Support our Research

    If you wish to support our mission, please consider a gift to the Women’s Cancer Fund for Biology, Treatment, and Cure through the University of Michigan Rogel Cancer Center.

    Gifts to this fund are crucial to advancing science at the bedside as discovery continues to provide improved outcomes for people diagnosed with a gynecologic cancer, as well as hope that diseases unique to women will someday be eliminated.

    Locations
    • Gynecologic Oncology Clinic | Rogel Cancer Center 1500 E Medical Center Dr
      Floor 1
      Ann Arbor, MI 48109-5902       Get Directions
    • Oncology Clinic | Brighton Center for Specialty Care 7500 Challis Rd
      Entrance1, Level 1
      Brighton, MI 48116-9416       Get Directions

    Doctors

     Search for a U-M Health doctor     Stefany Acosta-Torres, MD

    Stefany Acosta-Torres, MD

    Clinical Assistant Professor

    Gynecological Oncology, Obstetrics & Gynecology

    Sarah Grace Bell, MD

    Sarah Grace Bell, MD

    Clinical Assistant Professor

    Gynecological Oncology, Obstetrics & Gynecology

    Melissa Wylie Brackmann, MD

    Melissa Wylie Brackmann, MD

    Clinical Assistant Professor

    Gynecological Oncology, Obstetrics & Gynecology

    Richard William Lieberman, MD

    Clinical Professor

    Obstetrics & Gynecology, Anatomic Pathology

    Aimee Marie Rolston, MD

    Aimee Marie Rolston, MD

    Clinical Assistant Professor

    Gynecological Oncology, Obstetrics & Gynecology

    Shitanshu Uppal, MD

    Shitanshu Uppal, MBBS, MBA

    Clinical Professor

    Gynecological Oncology, Obstetrics & Gynecology

    Zhen Ni Zhou, MD

    Zhen Ni Zhou, MD, PhD

    Clinical Assistant Professor

    Gynecological Oncology, Obstetrics & Gynecology

    Providers

     Search for a U-M Health provider     Olivia Anna De Bear, PA-C

    Olivia Anna De Bear, PA-C

    Physician Assistant

    Physician Assistant

    Michigan Photo

    Lisa Marie Spratke, PA-C

    Physician Assistant

    Physician Assistant

    Michigan Photo

    Cynthia Ann Stroup, PA-C

    Physician Assistant

    Physician Assistant

    Christine Wisniewski Willacker, PA-C

    Christine Wisniewski Willacker, PA-C

    Physician Assistant

    Physician Assistant

    News & Stories
    Woman's torso in a blue hospital gown, with her hands holding a pregnant belly and an IV in place.
    Health Lab

    High dose oxytocin protocol linked to lower postpartum hemorrhage rates

    A change in how oxytocin is administered after childbirth may help reduce postpartum hemorrhage, a new study suggests.
         pattern up close sequencing gene navy yellow
    Health Lab

    Comprehensive DNA sequencing reveals hidden drivers of cancer

    Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
         cancer cell blue yellow
    Health Lab

    ‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

    University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
         female surgeon on ground upset hands to face in scrubs and scrub shoes
    Health Lab

    Depression in OBGYN residents needs more attention, study suggests

    New onset depression in obstetrics and gynecology residents in their intern year is common and often untreated, and linked to depression history, higher work hours and less sleep.
         red blood cells going through clear tube red background
    Health Lab

    FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

    FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.
         little girl with yellow shirt on soccer field smiling ready for soccer
    Health Lab

    Pediatric patient treated for rare kidney cancer

    When 18-month-old Maria was diagnosed with an exceptionally rare kidney cancer, specialists at C.S. Mott Children's Hospital created a customized treatment plan that saved her life.